# Anti-shivering Effect of Ondansetron

> **NCT03530007** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Assiut University** · enrollment: 120 (estimated)

## Conditions studied

- Shivering
- Ondansetron

## Interventions

- **DRUG:** Normal saline
- **DRUG:** Ondansetron 4 MG
- **DRUG:** Ondansetron 8mg

## Key facts

- **NCT ID:** NCT03530007
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-05-15
- **Primary completion:** 2018-08-15
- **Final completion:** 2018-09-15
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2018-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03530007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03530007, "Anti-shivering Effect of Ondansetron". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03530007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*